Xenon Pharmaceuticals Inc.
XENE• NGM• Healthcare
$66.74
+0.70+1.06%
PE (TTM)
—
Sector: 24.87
Dividend Yield
—
Sector: 1.85%
Profit Margin
-4612.13%
Sector: 10.50%
Revenue Growth (YoY)
-100.00%
Sector: +7.05%
FCF Yield
-5.31%
Sector: 4.61%
"Sector" = median of Healthcare across 84 companies
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: December 2025 · 2025-12-31
Revenue
$0.00
Net income
-$105.26M
Free cash flow
-$81.80M
Diluted EPS
—
Gross margin
—
Profit margin
—
Assets
$981.67M
Cash
$199.16M
Valuation
Market Cap$6.45B
Enterprise Value$4.70B
PE (TTM)—
PE (Fwd)0.00
Price to Sales702.66
EV / EBITDA34.16
Price to Book7.59
PEG Ratio-0.06
Cash Flow
FCF Yield-5.31%
FCF / Share-$3.53
SBC-Adj FCF Yield-6.33%
SBC-Adj FCF / Share-$4.21
SBC Impact+19.19%
Margins & Growth
Gross Margin66.09%
Operating Margin-4974.27%
Profit Margin-4612.13%
Quarterly Rev YoY-100.00%
Quarterly EPS YoY-60.25%
Balance
Cash$199.16M
Debt$1.53M
Net Debt-$197.63M
Current Ratio13.42
Debt / Equity0.26
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
+206.49%
Jul 22, 2021 - Apr 29, 2026 · 1,198 daily points
Revenue
Net Income
↓ 1306.5%Free Cash Flow
↓ 496.5%Diluted EPS
No data
Quick Stats
Open
$66.40
Day High
$66.86
Day Low
$65.78
Prev Close
$66.04
Market Cap
—
Volume
832,600
Xenon Pharmaceuticals Inc. (XENE) analysis
Wrqti brings Xenon Pharmaceuticals Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$66.74
Market cap
$6.45B
PE ratio
—
Price to book
7.59
Profit margin
-4612.13%
FCF yield
-5.31%
Stocks related to Xenon Pharmaceuticals Inc.
Companies in the Healthcare sector you can compare with Xenon Pharmaceuticals Inc.: